Replies to post #337296 on Avid Bioservices Inc (CDMO)

[peregr]

I wouldn't say no good news-the expansion is great news and as I posted earlier, the article in BioProcess now defines the expansion will not be sequential but the second phase already started and is concurrent. That was still a question mark from the last call. That, is pretty relevant as it brings in revenues much quicker. Now if Nick is smart, and I think he and the Board are, he will announce that the expansion is fully secured and financed with incremental revenues from.....

If not and we just get a repeat and no increase in guidance, then the sell off today is fully justified. Hard to see $22M quarterly revenue justifying a $1.3B market cap. But we easily get there.